中國乘聯會:5月首周新能源車市場零售較去年同期增近1.3信
中國乘用車市場信息聯席會公布數據顯示,5月1日至7日,乘用車市場零售37.5萬輛,較去年同期增長67%,較上月同期增長46%。今年以來累計零售627萬輛,按年增長1%。乘用車廠商批發19.2萬輛,較去年同期下降1%,較上月同期下降1%;今年以來累計批發703.4萬輛,按年增長7%。
期內,新能源車市場零售9.9萬輛,較去年同期增長128%,較上月同期增長38%。今年以來累計零售194.3萬輛,按年增長39%。乘用車廠商新能源批發6.8萬輛,較去年同期增長35%,較上月同期增長8%。今年以來累計批發210.8萬輛,按年增長32%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.